| Literature DB >> 25135970 |
Jonathan E Cohen1, Philip R Lee1, R Douglas Fields2.
Abstract
Ongoing neuronal activity during development and plasticity acts to refine synaptic connections and contributes to the induction of plasticity and ultimately long-term memory storage. Activity-dependent, post-transcriptional control of mRNAs occurs through transport to axonal and dendritic compartments, local translation and mRNA stability. We have identified a mechanism that contributes to activity-dependent regulation of mRNA stability during synaptic plasticity in rat hippocampal neurons. In this study, we demonstrate rapid, post-transcriptional control over process-enriched mRNAs by neuronal activity. Systematic analysis of the 3'-UTRs of destabilized transcripts, identifies enrichment in sequence motifs corresponding to microRNA (miRNA)-binding sites. The miRNAs that were identified, miR-326-3p/miR-330-5p, miR-485-5p, miR-666-3p and miR-761 are predicted to regulate networks of genes important in plasticity and development. We find that these miRNAs are developmentally regulated in the hippocampus, many increasing by postnatal day 14. We further find that miR-485-5p controls NGF-induced neurite outgrowth in PC12 cells, tau expression and axonal development in hippocampal neurons. miRNAs can function at the synapse to rapidly control and affect short- and long-term changes at the synapse. These processes likely occur during refinement of synaptic connections and contribute to the induction of plasticity and learning and memory.Entities:
Keywords: 3′-UTR; activity-dependent plasticity; mRNA stability; miRNA
Mesh:
Substances:
Year: 2014 PMID: 25135970 PMCID: PMC4142030 DOI: 10.1098/rstb.2013.0509
Source DB: PubMed Journal: Philos Trans R Soc Lond B Biol Sci ISSN: 0962-8436 Impact factor: 6.237
Figure 1.Activity-dependent, post-transcriptional gene regulation experiment. Cultured hippocampal neurons were pre-incubated with an inhibitory drug cocktail (50 µM 2-amino-5-phosphonovalerate (APV), 40 µm 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 100 nM tetrodotoxin (TTX)) to block spontaneous activity for 3 h. Repetitive action potential firing was then induced by washing out the blockers (three changes of media) and adding 50 µM bicuculline (BiC) and 500 µM 4-aminopyridine (4-AP)) [23]. Transcription was blocked in one set of the cultures with 25 µm actinomycin D. In parallel, control cultures were treated with DMSO and maintained in the inhibitory cocktail. After 5 min, RNA was either harvested (5 min) or media was replaced with fresh media lacking BiC/4-AP.
Destabilized transcripts are enriched in GO terms associated with axonal development and synaptic vesicles.
| condition | GO term | no. genes | |
|---|---|---|---|
| downregulated (410) | neuron projection | 31 | 9.1 × 10−11 |
| neuron differentiation | 22 | 1.3 × 10−4 | |
| synapse | 22 | 1.9 × 10−4 | |
| membrane-bound vesicle | 23 | 1.9 × 10−4 | |
| ion binding | 77 | 2.1 × 10−4 | |
| regulation of transcription | 25 | 3.9 × 10−4 | |
| upregulated (148) | ribosome | 6 | 2.5 × 10−4 |
| vesicle | 12 | 1.6 × 10−3 | |
| long-chain fatty acid transport | 3 | 1.1 × 10−2 | |
| nucleolus | 6 | 2.7 × 10−2 | |
| non-regulated (136) | non-membrane-bounded organelle | 28 | 2.3 × 10−4 |
| ribosome | 6 | 2.6 × 10−4 | |
| T-cell activation | 5 | 1.9 × 10−3 | |
| enzyme binding | 11 | 2.1 × 10−3 |
GO analysis was performed on z-fold normalized microarray data from Illumina microarrays with a threshold of |z-fold| > 1.3 for both actinomycin D pre-treated and control cultures treated with BiC/4-AP for 5 min. Non-regulated transcripts were defined as those transcripts for all of the microarray samples where |z-fold| < 1. Top functions were identified from the DAVID [34,35] using functional annotation clustering and medium classification stringency. Downregulated or destabilized genes were mapped to functions and pathways important in nervous system development, e.g. neuron projection, synapse.
Figure 2.(Opposite.) Rapid, post-transcriptional regulation in hippocampal neurons mirrors activity-regulated genes in DRG axons. Hierarchical clustering of microarray expression data shows the regulation of hundreds of genes following neural activity in cultured hippocampal neurons and DRG neurons. These results were compared against gene expression changes in DRG neurons following 2 h of patterned electrical stimulation by z-fold normalized expression changes in post-transcriptional gene expression at 5, 30 and 60 min in hippocampal neurons (±actinomycin D) following a short synaptic stimulus (5 min BiC/4-AP). DRG neurons were electrically stimulated in multi-compartment chambers (electronic supplementary material, figure S1) in order to measure changes in gene expression in axons (DRG axons) and cell bodies (DRG cell bodies) separately. Unsupervised hierarchical clustering of microarray data from MGC nylon membranes is shown. In b (upregulated) and c (downregulated) are example clusters from a, further demonstrating co-regulation of transcripts in DRG axons and hippocampal neurons by a post-transcriptional mechanism.
Figure 3.Discovery of enriched motifs for destabilized and stabilized genes. 3′-UTR analysis by MEME on downregulated (destabilized) and upregulated (stabilized) transcripts by MEME identifies miRNA-binding sites. Motifs from MEME analysis are shown for destabilized (a) and stabilized (b) datasets. 3′-UTR DNA sequences for regulated transcripts were retrieved from the rn5 assembly of the UCSC Genome Browser and analysed for motifs on the given strand for any number of repetitions, allowing for motifs of either an eight-base fixed width or a variable length between seven and 15 bases. The likelihood of discovery for the indicated motifs by chance is shown as an E-value. For each discovered motif, WebLogo plots [46] are shown as well as either a predicted miRNA seed match or match to variable-width motif (electronic supplementary material, figure S2). Only motifs with E-values less than 0.15 are reported.
MAST analysis of MEME predicted 3′-UTR motifs.
| cluster | destabilized | score |
|---|---|---|
| 1 | transcriptional regulation | 11.0 |
| 2 | embryonic morphogenesis/development | 8.5 |
| 3 | vasculature development | 8.4 |
| 4 | neuron differentiation/morphogenesis/axon guidance | 7.7 |
| 5 | negative regulation of gene expression | 7.2 |
| 6 | nuclear/organelle lumen | 5.9 |
| 7 | regulation of cell motion/migration | 5.5 |
| 8 | limb morphogenesis/development | 5.5 |
| cluster | stabilized | score |
| 1 | transcriptional regulation-positive | 8.9 |
| 2 | transcriptional regulation | 7.0 |
| 3 | cell projection/dendrite/soma | 5.9 |
| 4 | membrane fraction | 5.3 |
| 5 | cytoplasmic vesicle | 5.0 |
| 6 | protein dimerization/binding | 4.9 |
| 7 | synapse/post-synaptic membrane | 4.8 |
| 8 | embryonic development | 4.7 |
| cluster | non-regulated | score |
| 1 | transcriptional regulation | 6.8 |
| 2 | vasculature development | 3.8 |
| 3 | cell migration/motility | 3.7 |
| 4 | nuclear/organelle lumen | 3.6 |
| 5 | negative regulation of gene expression | 3.4 |
| 6 | embryonic development | 2.9 |
| 7 | skeletal development | 2.8 |
| 8 | embryonic morphogenesis/development | 2.4 |
| cluster | destabilized (8nt) | score |
| 1 | embryonic morphogenesis/development | 2.0 |
| 2 | cell projection/cytoskeleton | 1.8 |
| 3 | protein dimerization/binding | 1.7 |
| 4 | transcriptional regulation | 1.7 |
| 5 | post-synaptic membrane/synapse | 1.6 |
| 6 | embryonic organ development/morphogenesis | 1.5 |
| 7 | cell differentiation | 1.5 |
| 8 | reproduction | 1.5 |
GO analysis was performed on MAST predictions for destabilized and stabilized motif sequence. Top functions for each GO cluster were identified using DAVID functional annotation tools. Predicted transcripts were mapped to functions and pathways important in development, morphogenesis and cell polarization. GO enrichment for transcriptional regulation was present for all three conditions. MAST predictions with an E-value < 0.001 for variable-width motifs or E-value < 1 for fixed-width motifs (90 DAVID IDs or 107 transcripts) were analysed by DAVID. In total, 1360 DAVID IDs (1584 transcripts) were analysed for destabilized motif set, 1761 DAVID IDs (2105 transcripts) for stabilized set and 331 DAVID IDs (391 transcripts) for the non-regulated set. Calculated group enrichment scores for each GO cluster were calculated from the geometric mean (-log scale) of the p-value in each corresponding annotation cluster to rank biological significance. Top ranked annotation groups (highest score) likely have lower p-values for their annotated members.
Figure 4.Predicted miRNAs are developmentally regulated in the hippocampus and may control nervous system development. (a) Venn diagram of miRNA target predictions (TargetScan v. 6.2) for miR-326-3p/330-5p, miR-485-5p, miR-666-3p and miR-761. Less than 15% of predicted targets are shared between any two miRNAs. The numbers in parentheses refer to the number of annotated genes predicted to contain at least one conserved miRNA-binding site. Specific targets are given in the electronic supplementary material, table S2. (b) Venn diagram of GO analysis for miRNA target predictions given in the electronic supplementary material, table S2. The number in parentheses refers to the number of significant GO terms with p-value ≤ 0.01. Eighteen GO terms were found to be enriched for all four miRNAs investigated, showing enrichment for nervous system development and morphogenesis. (c) Predicted miRNA transcripts were developmentally regulated in the hippocampus. The increase in miRNA transcripts from embryonic day 18.5 (E18.5) through postnatal day 21 (P21) (n = 3 animals at each time point) were first normalized to the reference gene U6 snRNA and the abundance expressed relative to E18.5. Fold induction of miRNAs varied from threefold to 12-fold.
Top networks and pathways of miRNA predicted targets identified by ingenuity pathway analysis.
| miRNA | network or pathway | no. genes | |
|---|---|---|---|
| miR-326-3p/330-5p (292) | neurological disease | 61 | 9.34 × 10−5 – 1.38 × 10−2 |
| cell morphology | 88 | 1.15 × 10−8 – 1.38 × 10−2 | |
| CNS development and function | 86 | 2.81 × 10−9 – 1.38 × 10−2 | |
| Wnt/B-catenin | 4.67 × 10−6 | ||
| actin cytoskeleton | 4.43 × 10−5 | ||
| axonal guidance | 3.24 × 10−4 | ||
| miR-485-5p (245) | neurological disease | 51 | 2.32 × 10−5 – 1.57 × 10−2 |
| cell morphology | 61 | 1.4 × 10−4 – 1.51 × 10−2 | |
| CNS development and function | 61 | 6.75 × 10−7 – 1.57 × 10−2 | |
| circadian rhythm signalling | 6.74 × 10−4 | ||
| agrin interactions at neuromuscular junction | 1.27 × 10−3 | ||
| axonal guidance signalling | 1.36 × 10−2 | ||
| miR-666-3p (289) | developmental disorder | 53 | 1.11 × 10−4 – 1.63 × 10−2 |
| gene expression | 71 | 9.13 × 10−7 – 1.62 × 10−2 | |
| CNS development and function | 65 | 3.69 × 10−5 – 1.89 × 10−2 | |
| protein kinase A signalling | 3.09 × 10−3 | ||
| synaptic long-term potentiation | 7.2 × 10−3 | ||
| dopamine-DARPP32 feedback in cAMP | 8.65 × 10−3 | ||
| miR-761 (514) | cancer | 256 | 5.07 × 10−5 – 1.32 × 10−2 |
| cell morphology | 97 | 5.53 × 10−8 – 1.36 × 10−2 | |
| CNS development and function | 118 | 1.11 × 10−7 – 1.36 × 10−2 | |
| axon guidance signalling | 6.93 × 10−4 | ||
| RAN signalling | 7.63 × 10−4 | ||
| netrin signalling | 2.97 × 10−3 |
miR-326/miR-330 top canonical pathways.
Wnt/B-catenin: BTRC, CDH3, CSNK2A1, FZD4, FZD5, MARK2, NLK, PPP2R5B, RARG, SOX12, TCF4, TLE3.
Actin cytoskeleton: ABI2, F2R, FGD3, FGF9, FGF11, ITGA5, MAPK1, NRAS, PIP4K2C, SSH2, SOS1, TLN.
Axonal guidance: ADAM19, C9orf3, EFNA3, EPHB3, FZD4, FZD5, ITGA5, ITSN1, MAPK1, NGFR, NTN1, NRAS, PDIA3, SEMA3G, SRGAP3, SOS1.
miR-485 top canonical pathways.
Circadian rhythm signalling: GRIN1, ADCYAP1R1, CRY2, CREB1.
Agrin interactions at NMJ: PAK4, PAK1, DAG1, ACTG1, ITGAL.
Axonal guidance signalling: ARHGEF15, BAIAP2, EFNB3, PAK1, PAK4, PLCD3, PLXNA2, PFN2, PPP3R1, SEMA4G, SRGAP2.
miR-666-3p top canonical pathways.
Axon guidance signalling: AKAP6, CALM1 (includes others), CAMK2G, CREB5, EYA3, GNG12, PDE7A, PPP1CA, PPP1R10, PTPN2, RAP1B, TCF4, YWHAQ.
Synaptic long-term potentiation: CALM1 (includes others), CAMK2G, CREB5, PPP1CA, PPP1R10, RAP1B.
Dopamine-DARPP32 feedback in cAMP: CALM1 (includes others), CACNA1D, CSNK1G1, PPP1R10, CREB5, PPP1CA, DRD2.
Ingenuity pathway analysis was performed on predicted targets of miR-326-3p/miR-330-5p, miR-485-5p, miR-666-3p and miR-761 using the TargetScan v. 6.2 algorithm [49–51]. Predicted targets were mapped to specific biological functions and pathways: (i) disease and disorders, (ii) molecular and cellular functions, (iii) physiological system development and function, and (iv) top canonical pathways. Ingenuity's function analysis identified several biological functions and diseases most significant to genes within a network. The probability that a function or pathway was due to chance alone or enriched was determined by a Fisher's exact test. The top functions are shown, demonstrating that enriched miRNA sites are predicted to regulate morphogenesis, neural development and synapse formation. The complete list of predicted miRNA targets is given in the electronic supplementary material, table S2. The p-values in the range shown were considered highly significant.
Figure 5.miR-485 blocks NGF-induced neurite outgrowth in PC12 cells. miR-485 overexpression inhibits NGF-induced neurite outgrowth in PC12 cells. Shown in (a) are representative examples of PC12 cells treated with 50 ng ml−1 NGF and co-transfected with DsRed and miR-485 mimic, miR-inhibitor and negative controls, and analysed at 96 h. Scale bar, 25 μm. Neurite outgrowth was inhibited by overexpression of a miR-485-5p mimic (p < 0.001) and enhanced by a miR-485 inhibitor (p < 0.001). PC12 cells with neurites longer than twice the cell body diameter were scored positive for neurite outgrowth (NOI). The NOI in untreated PC12 cells was 0.45 ± 0.02; treatment with negative controls for the mimic (-co. miR-M, 0.44 ± 0.04) or inhibitor (-co. miR-I, 0.43 ± 0.03) did not affect the NOI. n = 6 for all tested conditions. Effects of miR-M and miR-I on NOI were highly significant by one-way ANOVA (F25,4 = 26.15, p < 0.001). Overexpression of either a negative control for the miRNA precursor or the inhibitor did not significantly affect the NOI. Scale bar, 25 μm; **p < 0.01; ***p < 0.001.
Figure 6.miR-485 decreases tau expression in hippocampal neurons. Overexpression of miR-485-5p modestly decreased tau transcript abundance (a) and protein levels (b) in hippocampal neurons. Cultures were transfected with miRNAs at 7 days in vitro (DIV) and analysed at 12 DIV. Fold change in transcript abundance for miR-overexpression and inhibition were normalized to their respective negative controls (negative control for either the mimic or inhibitor). Tau protein levels decreased relative to total GAPDH protein expression. Treatment with negative controls for either the mimic or inhibitor did not alter transcript levels for tau protein. n = 3, p < 0.05.
Figure 7.miR-485 overexpression controls tau expression and axonal outgrowth in hippocampal neurons. miR-485-5p overexpression reduced the extent of axonal outgrowth in hippocampal neurons. Cultures were co-transfected with DsRed and miRNAs at 7 DIV and analysed by immunocytochemistry at 12 DIV for axons by either tau or the pan-axonal neurofilament marker, SMI312. Dendritic staining was assessed by immunostaining for MAP2. Shown are representative examples of untreated (control) and neurons transfected with either a miRNA mimic or inhibitor showing that axonal outgrowth is regulated by miR-485-5p. Treatment with negative controls for either a miRNA mimic or inhibitor did not alter either axonal or dendritic staining. Double labelling with axonal and dendritic markers showed little co-localization. Scale bar, 25 μm.